DIM 78.39 ▼ -0.38% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AMEX: DIM · Real-Time Price · USD
    78.39
    -0.30 (-0.38%)
    At close: Sep 12, 2025, 12:40 PM
    -0.38%
    Bid 78.38
    Market Cap 159.21M
    Revenue (ttm) n/a
    Net Income (ttm) n/a
    EPS (ttm) 5.5091195
    PE Ratio (ttm) 14.23
    Forward PE n/a
    Analyst n/a
    Ask 78.5
    Volume 836
    Avg. Volume (20D) 7,038
    Open 78.42
    Previous Close 78.69
    Day's Range 78.36 - 78.42
    52-Week Range 59.38 - 79.72
    Beta n/a

    About DIM

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol DIM
    Website n/a
    Full Company Profile
    news image

    3 years ago · seekingalpha.com

    A Deeper Look At Our International Dividend Index Rebalance

    A Deeper Look At Our International Dividend Index Rebalance

    news image

    5 years ago · investorplace.com

    10 Mid-Cap ETFs to Buy for Next Decade

    Whether you're an expeienced investor or new to the game, these 10 mid-cap ETFs are great additions to your portfolio for the next decade.

    news image

    5 years ago · businesswire.com

    Nine-month Figures For 2019: Sartorius Stedim Biotech Reports Double-digit Sales Growth

    AUBAGNE, France--(BUSINESS WIRE)--Regulatory News: Sartorius Stedim Biotech (SSB) (Paris:DIM), a leading partner of the biopharma industry, has continued on its growth track, and reported a double-dig...

    news image

    6 years ago · businesswire.com

    Nine-Month Figures for 2018: Sartorius Stedim Biotech Continues to Grow by Double Digits

    AUBAGNE, France--(BUSINESS WIRE)--Regulatory News: With double-digit increases in sales revenue and earnings, Sartorius Stedim Biotech (SSB) (Paris:DIM), a leading partner of the biopharma industry, c...

    news image

    7 years ago · businesswire.com

    Business Figures for the First Half of 2018: Sartorius Stedim Biotech Records Double-Digit Growth in Sales and Profit

    AUBAGNE, France--(BUSINESS WIRE)--Regulatory News: Sartorius Stedim Biotech (SSB)(Paris:DIM), a leading partner of the biopharma industry, has continued on the growth track, delivering double-digit in...

    news image

    7 years ago · businesswire.com

    First-Quarter Figures: Sartorius Stedim Biotech off to a Dynamic Start into 2018

    AUBAGNE, France--(BUSINESS WIRE)--Regulatory News: Sartorius Stedim Biotech (SSB)(Paris:DIM), a leading partner of the biopharma industry, successfully started off the year 2018. “In the first quarter...

    news image

    7 years ago · businesswire.com

    Preliminary Results for 2017: Sartorius Stedim Biotech Grows in Revenue and Earnings – Positive Outlook for 2018

    AUBAGNE, France--(BUSINESS WIRE)--Regulatory News: Unaudited figures 1 According to customers’ location 2 Underlying EBITDA = earnings before interest, taxes, depreciation and amortization, adjusted f...

    news image

    7 years ago · businesswire.com

    Sartorius Stedim Biotech: Growth dynamics temporarily dampened; continued strong mid-term perspectives

    AUBAGNE, France & GOETTINGEN, Germany--(BUSINESS WIRE)--Regulatory News: 1 According to customers’ location2 Underlying EBITDA = earnings before interest, taxes, depreciation and amortization, and adj...

    news image

    8 years ago · businesswire.com

    Sartorius Stedim Biotech S.A.: 2017 First-Half Figures

    GOETTINGEN, Germany--(BUSINESS WIRE)--Regulatory News: Sartorius Stedim Biotech S.A. (Paris:DIM): 1 According to customers’ location2 Underlying EBITDA = earnings before interest, taxes, depreciation ...

    news image

    8 years ago · businesswire.com

    First-Quarter Figures: Sartorius Stedim Biotech Off to a Good Start in 2017

    GOETTINGEN, Germany--(BUSINESS WIRE)--Regulatory News: 1 According to customers’ location 2 Underlying EBITDA = earnings before interest, taxes, depreciation and amortization, and adjusted for extraor...

    Add to Watchlist